Atea Pharmaceuticals, Inc.

AVIR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$4.11-0.12%

2026-11-02

Financials

Valuation Metrics

Atea Pharmaceuticals, Inc.'s Market Cap is $329M. At end of 2025 it was $279M. Ranked #2879 of 3,118 in US market (top 92%), #1289 of 1,474 on NASDAQ (top 87%), #230 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 87%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$329M	US#2,879/3,118 Sec#230/265
Revenue	$0.00	US#2,858/3,118 Sec#193/265
Net Income	$-165M	US—/3,118 Sec—/265
Total Assets	$232M	US#2,957/3,118 Sec#236/265
Net Assets	$204M	US#2,664/3,118 Sec#191/265
Value
P/B	1.61x	US#988/3,118 Sec#43/265
FCF Yield	-46.29%	US—/3,118 Sec—/265
Profitability
ROE	-80.96%	US#2,763/3,118 Sec#195/265
ROA	-71.16%	US#3,027/3,118 Sec#241/265
Financial Health
Debt Ratio	13.78%	US#154/3,118 Sec#62/265
Total Debt	$424000.00	US#2,983/3,118 Sec#253/265
FCF	$-152M	US#2,716/3,118 Sec#180/265
Cash	$77M	US#2,371/3,118 Sec#195/265
Current Ratio	8.13x	US#307/3,118 Sec#95/265
Performance
1Y Return	26.31%	US#973/3,118 Sec#99/265
1M Return	-19.98%	US#2,823/3,118 Sec#229/265
From 52W High	-36.36%	US#2,209/3,118 Sec#153/265
1Y MDD	-34.31%	US#1,606/3,118 Sec#86/265
Trading
Volume	248,036 shares	US#2,429/3,118 Sec#231/265
Trading Value	$1M	US#2,978/3,118 Sec#253/265
Per Share
EPS	$-2.07	US—/3,118 Sec—/265
BPS	$2.55	US#2,526/3,118 Sec#166/265